Escitalopram in Adult Patients With Major Depressive Disorder

Summary

This is a short-term study to evaluate the efficacy, safety, and tolerability of escitalopram in adult patients (18 to 65 years of age) with moderate to severe depression. Patients completing the study may be eligible to enter a long-term open-label extension study with escitalopram.

Timeline

Start

2008-04

Primary completion

2009-02

Completion

—

Drugs

Indications